| Literature DB >> 34944426 |
Yoko Suzuki-Horiuchi1, Henning Schmitz1, Carlotta Barlassina1, David Eccles2, Martina Sinn2, Claudia Ortmeier1, Sören Moritz1, Luca Gentile1,2,3.
Abstract
Regeneration, the restoration of body parts after injury, is quite widespread in the animal kingdom. Species from virtually all Phyla possess regenerative abilities. Human beings, however, are poor regenerators. Yet, the progress of knowledge and technology in the fields of bioengineering, stem cells, and regenerative biology have fostered major advancements in regenerative medical treatments, which aim to regenerate tissues and organs and restore function. Human induced pluripotent stem cells can differentiate into any cell type of the body; however, the structural and cellular complexity of the human tissues, together with the inability of our adult body to control pluripotency, require a better mechanistic understanding. Planarians, with their capacity to regenerate lost body parts thanks to the presence of adult pluripotent stem cells could help providing such an understanding. In this paper, we used a top-down approach to shortlist blastema transcription factors (TFs) active during anterior regeneration. We found 44 TFs-31 of which are novel in planarian-that are expressed in the regenerating blastema. We analyzed the function of half of them and found that they play a role in the regeneration of anterior structures, like the anterior organizer, the positional instruction muscle cells, the brain, the photoreceptor, the intestine. Our findings revealed a glimpse of the complexity of the transcriptional network governing anterior regeneration in planarians, confirming that this animal model is the perfect playground to study in vivo how pluripotency copes with adulthood.Entities:
Keywords: RNA-seq; blastema; differentiation; planarian; pluripotency; regeneration; stem cells; transcription factors
Mesh:
Substances:
Year: 2021 PMID: 34944426 PMCID: PMC8698962 DOI: 10.3390/biom11121782
Source DB: PubMed Journal: Biomolecules ISSN: 2218-273X
Peer-reviewed articles presenting planarian transcriptome studies.
| No. | Year | Author | Transcriptome Analysis | Species | Sequencing Samples |
|---|---|---|---|---|---|
| 1 | 2010 | Blythe, et al. | 454, SOLiD3 |
| Regenerating fragments at 6, 12, 24, 36, 48, 72, 96, 120, 144 h |
| of anterior and posterior regeneration and intact | |||||
| 2 | 2010 | Abril, et al. | 454 |
| Mixed sample of intact and regenerating planarians (1, 3, 5, and 7 days), |
| Irradiates intact and regenerating animals (1, 3, 5, and 7 days of regeneration) | |||||
| 3 | 2011 | Qin, et al. | Illumina HiseqTM 2000 |
| Regenerating planarian from Day 1 to Day 10 and intact |
| 4 | 2011 | Adamidi, et al. | 454, Illumina GAIIX |
| Whole animal |
| 5 | 2011 | Sandmann, et al. | Illumina Genome Analyzer II |
| Regenerating head from 0 to 3 days |
| SOLiD3 |
| Regenerating head and tail regions at 0, 1, and 6 h after amputation | |||
| 6 | 2012 | Solana, et al. | SOLiD4 |
| Iraddiate animals at 2, 4, 7 days and wild type intact |
| 7 | 2012 | Shibata, et al. | HiCEP |
| Intact, Irradiated planarians, Neoblasts from X1/2 fractions |
| 8 | 2012 | Galloni, et al. | DGE |
| Irradiated and normal regenerating samples at 0–7 days after amputation |
| 9 | 2012 | Resch, et al. | Illumina GAIIX |
| non-irradiated or irradiated |
| 10 | 2012 | Nishimura, et al. | Sanger Sequences |
| Head fragments after amputation |
| 11 | 2012 | Lapan, et al. | Illumina Genome Analyzer II |
| Eyes, amputated heads (above the pharynx and coronal amputation was made to |
| remove dorsal tissues including eye) | |||||
| 12 | 2012 | Labbe, et al. | Illumina HiSeq 2000 |
| FACS sorted stem cells, irradiate animals at 7 days post irradiation |
| 13 | 2012 | Onal, et al. | Illumina Genome Analyzer II |
| X1, X2, Xin |
| 14 | 2013 | Sikes, et al. | Illumina Sequencing |
| Fragments of worms, intact |
| 15 | 2013 | März, et al. | Illumina HiScanSQ |
| Smed-pitx RNAi and control fragments at 3 days post amputation |
| 16 | 2013 | Kao, et al. | SOLiD3 |
| Regenerating head and tail fragments 0, 6, 12, 24, 46, 48, and 72 h after amputation. |
| 454 |
| Tail fragments of Smed- | |||
|
| Embryonic development (2-cell stage through nine days old embryos from multiple parents) | ||||
| 17 | 2014 | Srivastana, et al. | 454 |
| Regeneration at 1, 6, 18, 24, 72 h after amputation |
| 18 | 2014 | Vogg, et al. | Illumina HiScanSQ |
| FoxD RNAi tail stumps at 0 and 3 days post amputation and regenerating control |
| 19 | 2014 | Scimone, et al. | Illumina HiSeq |
| X1 isolation after amputation |
| 20 | 2015 | Reuter, et al. | Illumina HiScanSQ |
| dsRNA notum, 18 h post amputation |
| 21 | 2015 | Wheeler, et al. | Illumina HiSeq 2000 |
| Amputation, +serotonin, control |
| 22 | 2016 | Pang, et al. | Illumina HiSeq 2000 |
| Whole animal |
| 23 | 2016 | Molinaro, et al. | Illumina HiSeq 2500, Single Cell Seq |
| FACS sorted X1, X2 from head |
| 24 | 2018 | Almazan, et al. | Illumina HiSeq 2500 |
| Intact, 1, 4, days post amputation, Auricles |
| 25 | 2018 | Zeng, et al. | Illumina HiSeq 2500, scRNA-seq |
| Bulk RNA-seq of live cells and fixed cells (X1, X2, Xin), X1 neoblasts (200,000 cells) from |
| wild-type animals, X1 + X2 cells from 7 day sub-lethally irradiated animals | |||||
| 26 | 2018 | Mihaylova, et al. | Illumina NextSeq |
| FACS sorted G2/M cells from knockdown and control RNAi animals 3days of regeneration |
| 27 | 2018 | Ross, et al. | HiSeq 2000 |
| SoxB1-2 RNAi and control RNAi animals at day 6, 14, and 24 after the first RNAI treatment |
| scRNA-seq (Molinaro, et al., 2016) | |||||
| 28 | 2019 | Sekii, et al. | Illumina HiSeq 2000 |
| Asexual sample, Sexual sample, Innate Sexual sample |
| 29 | 2020 | Forsthoefel, et al. | Nextseq 500 |
| LCM (medial intestine, lateral intestine, non-intestine) |
Figure 1Experimental plan and sampling. (A) Schematics showing the experimental setup and the main techniques used to generate the shortlist of transcription factors involved in the anterior blastema regeneration. (B) Wild-type (a–f) and irradiated (g–l) animals 3 and 6 days after amputation in three fragments: head, trunk, and tail. (C) Day 3 wt trunk fragment under bright field and UV light illumination. The blastema is highly refractive under UV light, allowing the precise definition of the laser cut path (bottom). Red arrowhead: blastema-postblastema boundary; green line: laser cutting path (1st); red line: laser cutting path (2nd). (D) After RNA extraction and cDNA synthesis, the array of samples used in the study were assessed via qPCR for smedwi1, prog1, Agat1, and SmB (shown for SmB-KD sample only).
Figure 2RNA-seq data relative to the expression of known genes. (A) Relative expression of genes representative of the FACS cell fractions in X1, X2, and Xin RNA-seq samples. (B) Genes differentially expressed between anterior blastema (B) and the respective non-regenerating rest of the body (RoB) at day 3 (left panel) and day 6 (center panel) of regeneration or between anterior blastema day 3 and anterior blastema day 6 (right panel), represented as butterfly charts. The position of some representative genes is provided (red dots). A threshold of 1.5-folds was applied, the trendlines represent the ratio of the expression of the genes considered between the pairs of samples shown.
Figure 3RNA-Seq analysis pipeline. Alongside the core analysis of the raw data (assembly, mapping, and annotation), the complete pipeline also consisted of data sorting. Putative transcription factors active in the blastema were selected according to their relative expression level in the considered samples and their functional annotation (Blastx, InterProScan and GO). A total of 60 putative blastema transcription factors were eventually shortlisted.
Figure 4Sorting of the RNA-seq data. (A) A heat map was populated with 3586 genes that were sorted based on the differential expression among the samples, as explained in Figure 3. (B) The Pearson’s correlation based on the shortlist of 3586 genes showed how the samples analyzed in this study correlate expression-wise. Two main clusters of samples are visible: one that is stem cell-enriched (X1, X2 samples) and one that is non-stem cell-enriched (Xin, RoB, Irr d3, Irr d6, SmB(RNAi), blastema samples). Within the non-stem cell-enriched samples, the blastema samples clustered together in a sub-group (second most relevant hierarchical division). (C–E) The 3586 genes were grouped according to their molecular function (C). A lower hierarchical level of molecular functions was showed by the different classes of genes with binding activity (D). The pie chart showed how the 111 genes with nucleic acid binding activity distribute in the two main classes of nucleic acid binding: DNA- and RNA-binding (E).
Figure 5Expression of the shortlisted putative transcription factors in fragments at either day 3 or 6 of regeneration and in homeostatic animals, as for WISH. (A) SC-like patter of H2A. (B) Ets-1, Prep, ZicA, and FoxJ1 were expressed in the region anterior to the photoreceptors. (C) Rfc3 and Dr1 were expressed along the midline. (D) Irx3, Hsf1, and Pax2/5/8 were expressed only in regenerating fragments, either in the blastema or in other districts, but not in homeostatic animals. (E) Tbx2, Ap2, and Zgpat were expressed in the CNS. (F) Tcf15 and Elf4 were expressed in the mouth. (G) Egr1 and Zfp were expressed in the pharynx. (H) Hr96, FoxF, and Zmym6 were expressed in both mouth and pharynx. (I) Traf5, Etv6, and Nfat5 were expressed in the intestine. (J) Egr1 and Zfp were expressed in the testes. Scale bar: 1 mm.
Figure 6Expression of the shortlisted blastema transcription factors in day 3 blastema, as for WISH. Transcription factors expressed in the anterior blastema of tail fragments after 3 days of regeneration, except for Zmym6, which is shown in the anterior blastema of a trunk fragment. In green, two genes that are not transcription factors but have some transcriptional regulation activity (Smad4 and Smarcb1).
Figure 7Co-localization of the transcripts of the shortlisted TFs with those of tissue-specific markers. (A,B) Co-localization of Tbx2/3 (A) and Taf11 (B) mRNAs with the pan-neuronal marker PC2 (as for double-WISH) in day 3 blastema of regenerating head fragments. The areas in the upper panels surrounded with the yellow frames are enlarged in the respective lower panels. Scale bars: 50 μm. (C) Traf5 expressing cells are located around the gut linen, which is marked by porcupine (as for double-WISH), both at day 3 (upper and middle panels) and at day 6 (lower panel) of regeneration. Traf5 signal is stronger in the newly formed tissue close to the wound, especially in the early phase of regeneration (white arrowheads). The yellow frames in the upper panel show the regions enlarged in the middle panel. Scale bars: 50 μm. (D–F) Co-localizion of Six-1 (D), FoxF (E), or MyoD (F) mRNAs with Myhc mRNA (as for double-WISH) in blastema at day 3 of regeneration. The areas in the upper panels surrounded with the yellow frames are enlarged in the respective lower panels. Scale bars: 50 μm. (G) Cells co-expressing Zfp mRNA with the germinal histone 4 mRNA, in the trunk fragment of planarians at day 6 of regeneration. Either double-positive or double-negative cells are visible. The inserts show an enlargement of the areas surrounded by the yellow frames. Scale bars: 50 μm.
Figure 8The knock-down of the blastema transcription factors resulted in regeneration defects. (A) Following dsRNA-mediated gene knock-down, most of the blastema transcription factors tested resulted in regeneration defects. The Knock-down of Smad4, Lmh1a, and Egr1 resulted in tail regeneration defects (n = 7/9, 13/17, 17/24, respectively) and occasionally in eye regeneration defects (n = 3/9, 4/8, 20/43, respectively). The knock-down of Zfp, Fli1, Tigd1 and Six-1 resulted in a blastema of a reduced size, regardless of the fragment considered (n = 32/42, 41/53, 11/19, 16/23, respectively). The Knock-down of Zfp, MyoD, Isl-1 and Tbx2/3 resulted in eye regeneration defects (n = 21/23, 26/26, 10/10, 9/13, respectively). The Knock-down of Traf5 and Etv6 resulted in gut regeneration defects and the formation of body-wide lesions (n = 14/16, 20/20, respectively). (B) In spite of the regeneration defects displayed, most of the knocked-down genes did not alter significantly the lethality rate; exceptions to this rule were Etv6, with an average lethality of almost 50% at 9 dpa (n = 27/60) and MyoD, with a lethality rate >50% but limited to the head fragments (n = 48/60). (C) The immunostaining against arrestin (VC-1) showed that the knock-down of virtually all genes that produced tail, blastema or eye regeneration defects resulted also in the mis-projection of the visual neurons (e.g., Zfp, MyoD, Tbx2) or the reduced size of the photoreceptors (e.g., Egr1, Fli1, Tigd1, Six-1). Scale bars in C: 50 μm.
Figure 9The blastema transcriptional regulatory genes landscape. The transcription factors expressed by the cells within the blastema could be either restricted to a specific lineage/tissue or not, as emerged from WISH and RNAi data. (functionally-validated genes are shown in bold).